Pliant Therapeutics Inc (PLRX): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 2,5 US Dollar | 1 | 1 | 11 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 61.921.897 | 4,57 | 5,28 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Pliant Therapeutics Inc
Mitarbeiter 49
Handelsplatz NASDAQ
Ticker Symbol PLRX
IPO Datum 2020-06-03
Adresse 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://pliantrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Bernard Coulie M.B.A., M.D., Ph.D. | President, CEO & Director |
| 2 | Dr. Keith Lamont Cummings M.B.A., M.D. | Chief Financial Officer |
| 3 | Ms. Minnie Kuo | Chief Operating Officer |
| 4 | Dr. Rik Derynck Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
| 5 | Mr. Dean Sheppard M.D. | Scientific Founder & Member of Scientific Advisory Board |
| 6 | Mr. Hal Chapman M.D. | Scientific Founder & Member of Scientific Advisory Board |
| 7 | Ms. Delphine Imbert Ph.D. | Chief Technical Officer |
| 8 | Mr. Christopher S. Keenan | Vice President of Investor Relations & Corporate Communications |
| 9 | Monica Sandberg Ph.D. | Vice President, Regulatory & Compliance |
| 10 | Ms. Lily Cheung | Chief Human Resources Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 9,92% | 7,13 Mio. USD |
| 2 | Citadel Advisors Llc | 5,21% | 3,74 Mio. USD |
| 3 | ADAR1 Capital Management LLC | 4,17% | 3,00 Mio. USD |
| 4 | Acadian Asset Management LLC | 3,90% | 2,80 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 3,78% | 2,72 Mio. USD |
| 6 | Two Sigma Investments LLC | 3,64% | 2,61 Mio. USD |
| 7 | Monaco Asset Management | 3,13% | 2,25 Mio. USD |
| 8 | Renaissance Technologies Corp | 2,99% | 2,15 Mio. USD |
| 9 | Lynx1 Capital Management, LP | 2,90% | 2,09 Mio. USD |
| 10 | Woodline Partners LP | 2,69% | 1,93 Mio. USD |
| 11 | BML Capital Management LLC | 2,50% | 1,79 Mio. USD |
| 12 | Prosight Management, LP | 2,21% | 1,59 Mio. USD |
| 13 | Peapod Lane Capital LLC | 2,11% | 1,52 Mio. USD |
| 14 | BlackRock Inc | 1,77% | 1,27 Mio. USD |
| 15 | UBS Group AG | 1,71% | 1,23 Mio. USD |
| 16 | Marshall Wace Asset Management Ltd | 1,61% | 1,16 Mio. USD |
| 17 | Eversept Partners, LP | 1,44% | 1,03 Mio. USD |
| 18 | JPMorgan Chase & Co | 1,39% | 1,00 Mio. USD |
| 19 | Redmile Group, LLC | 1,25% | 0,90 Mio. USD |
| 20 | Jacobs Levy Equity Management, Inc. | 1,16% | 0,83 Mio. USD |